Pfizer Awards

Pfizer- IIT Delhi Innovation and IP Program (PIIP)

Pfizer and IIT Delhi have come together to launch an Innovation and IP Program under its CSR activity. Under the bilateral MoU, the program is operated by Foundation for Innovation and Technology Transfer (FITT) at IIT-Delhi to (i) create intellectual property based innovations / new business in the Healthcare sector - through the incubator route, and also (ii) support / promote creation of new Intellectual Properties in that sector. Winners in each category is done by open advertisement for participation, followed up with a rigorous selection process.

In the first round of the maiden Year (2015-16), (i) two grantees have been awarded with incubation grant award of Rs. 50 lakh each (see below for details of the awardee’s), (ii) 3 inventors with grant-award upto to Rs. 3 lack each for IP registration. The grantees have been awarded at a ceremony held on the 27th July, 2016 at the Senate Room, IIT Delhi. The event was attended by senior officials from Pfizer, IIT Delhi besides innovators.

Start up 1: Valetude Primus Healthcare Pvt Ltd

A startup by IIT Delhi PhD students (Mr Saurabh singh from Kusuma School of Biological Science and Mr Vikas Pandey from Department of Chemical Engg). They are mentored by Dr Ravikrishnan E from Biochemical Engg, Dr Vivekanandan P from Kusuma School of Biological science and Dr Shalini Gupta from Chemical Engineering.

Team is developing a rapid diagnostics method for typhoid infection with a turnaround time of 5-7 hours. Typhoid is one of the major threats that tolls nearly 1 million lives each year worldwide and is caused by by intake of contaminated food and water with gram-negative bacterium, Salmonella typhi. Current gold standard method to diagnose a bacterial infection is blood culture method, takes 24 to 72 hours to confirm the disease.

Start up 2: 'Nosacle': A novel wearable air purification device

A project by Debayan saha and Shashi Ranjan, Stanford India Biodesign 2015 fellow.

Air pollution claims 8 million pre-mature deaths world-wide. In India, every year 660 million people lose 3 years of their life owing to exposure to air pollution which causes deadly respiratory and cardiovascular diseases and children are the worst sufferer. Currently, there is no appropriate solution to tackle this emergency hence we the 'Stanford India Biodesign' 2015, fellows are developing a novel wearable device, with unique air-purification technology to empower individuals with the “Right to Breathe” pure air. The device will ensure purification efficiency comparable to the gold standard but at negligible resistance to breathe, hence no suffocation. It will be very user-friendly and comfortable to wear and being barely visible to others, will motivate users for everyday use, everywhere.